Corporate flu vaccinations are fundamental medical programs for businesses who want to cover their workers and their central functions.
Each and every year there is the threat of an outbreak occurring when individuals are not immunized.
There is a litany of reasons why citizens miss out on receiving their annual injection.
From a lack of convenience and oversight to fears about cost or wild unfounded theories about potential side effects and symptoms, none of these considerations stand up to any form of scrutiny.
Let us discuss what risks are evident for local enterprises who allow their employees to miss out on their immunization.
Sick Staff Members
The fact of the matter is organisations who fail to institute corporate flu vaccinations as part of an annual medical program expose their staff members to genuine illness. Thankfully rates of illness and flu-related deaths have dropped over the ensuing years and decades as medical science continues to make breakthroughs on immunizing against evident strains of influenza. Yet this is an ongoing struggle and those employees who are at risk can very well hamper any progress made to spread disease. Sick staff makes for a costly exercise, but from a purely moral and ethical point of view, it is poor practice to ignore the benefits of these programs.
Threat of Flu Outbreak
Corporate flu vaccinations stop outbreaks from happening. These illnesses are very much contagious and the sooner a program can be booked and implemented, the sooner the spread can stop dead in its tracks. This is why companies should be encouraged to embrace these initiatives because peers who do not follow suit only increase the threat further. Previous outbreaks not only result in illness but in deaths for some citizens who are at a higher risk threshold than others.
Companies that argue they have too much to concern themselves with on a daily basis to avoid booking corporate flu vaccinations actually end up incurring greater costs. With employees absent at higher rates, resources suddenly become stretched and there is no intellectual property on sight to oversee basic tasks and oversight. This is where errors occur and where other businesses will incur a miniscule hit to their operations during corporate flu vaccinations, those who ignore their benefits end up dealing with a drop in performance as specialists are off site managing their illness. These programs end up becoming an investment.
Falling Short of Industry Standards
It is a reflection on the business and their priorities when they deem corporate flu vaccinations as an exercise that is below them. It illustrates that they are more willing to preference short-term logistical concerns over the health and welfare of their most important assets – their people. These acts work to drop industry standards where greed and profit are placed over any other consideration. But as we know, even this judgment is wildly misplaced. In 2019 it does not take much to erode confidence in a brand and once it becomes public that vaccinations are not included as part of policy, that disclosure can be genuine damaging as investors, partners and prospects look towards competitors.
It is sound practice for local businesses to engage medical enterprises who offer corporate flu vaccinations. These programs are incredibly effective, take little time to institute and ensures a company can roll on as usual whilst competitors struggle with high absentee rates. These injections often take up to two weeks to take effect and for Australian organisations, the ideal window is to book placements for April and May prior to the severe chill of winter hitting.